Сергей Пузанов – Multiple Sclerosis. Everything you need to know (страница 11)

To start, every single one of us carries cerebrospinal fluid—CSF. It bathes the brain and spinal cord, and it is structurally insulated from the rest of the body by a specialized filter: the blood-brain barrier. If the barrier gets damaged and begins letting background noise through, it is always a reason to investigate, but it is far from an exclusive marker for MS. A breach in the barrier can be triggered by absolutely anything—infections, physical trauma, localized inflammation, and a massive spectrum of autoimmune conditions.

When the blood-brain barrier is compromised, lymphocytes drift into the CSF. Don't panic—in and of itself, this isn't particularly dangerous. White blood cells are found in the spinal fluid of perfectly healthy people too. Most of the time, they are simply doing their standard janitorial work: hunting for viruses, bacteria, cellular debris, and other junk. After a while, the barrier patches itself up, and the situation returns to baseline—including on your MRI scans. "Burning lesions" appear precisely because of a breached barrier, and as soon as it heals, they dim or stop glowing altogether.

A single microliter of blood holds anywhere from 1,000 to 4,000 lymphocytes; a single liter holds 1 to 4 billion; and the entire bloodstream carries between 5 and 20 billion. This brings us to another massive misconception: lymphocytes are called blood cells, but the vast majority of them live completely outside the blood. The bulk of the population is dug into the lymph nodes, the spleen, the thymus, mucous membranes, and other strategic hubs of the immune grid. The total number of lymphocytes in the human body is estimated between 1 and 2 trillion, making the bloodstream just a tiny fraction of their massive collective force. During an active infection, the body can ramp up production exponentially through clonal division, causing their numbers to surge in a flash.

How often are defective lymphocytes manufactured? Constantly. But normally, they are wiped out immediately through built-in security protocols that force a rogue cell to commit cellular hara-kiri. Sometimes, however, a flawed T-cell slips through every layer of defense, survives, and takes up residence in a lymph node—becoming a ticking time bomb for an autoimmune reaction. If that T-cell subsequently manages to force its way into the brain tissue and mistakes myelin for an invader, it sounds a chemical siren and calls for backup. Up to a quarter of that backup force is made up of B-lymphocytes, which soon mutate into plasma cells upon arrival.

How many plasma cells actually set up antibody-manufacturing hubs inside the brain tissue of MS patients? Anywhere from a few hundred to several thousand, and they typically descend from just a few dozen clonal lines of B-lymphocytes. This does not mean only a few dozen physical cells are participating in the firefight; rather, it refers to the distinct variants of IgG antibodies—the specific configurations of the BCR receptors on the B-cells that breached the brain. Each of these antibody profiles can be printed by thousands of descendants of a single root B-cell, since B-lymphocytes multiply aggressively, scaling up their immunoglobulin assembly lines. Thus, while the number of distinct clones is discrete, the intensity of their manufacturing output can scale massively. The numbers here are staggering: a single standalone plasma cell can pump out roughly 2,000 antibodies every single second.

The average adult body carries about 150 ml of cerebrospinal fluid. During a standard lumbar puncture, doctors draw roughly 10 ml—about 6% of the total volume, which is drastically higher than the 0.1–0.2% sample taken for a routine blood test. Isolating the specific antibody synthesis profile requires only 2 to 3 ml; the rest goes to cytological, biochemical, and infectious panels. The real bottleneck of the spinal tap lies elsewhere: CSF requires exceptionally delicate handling and rapid transport. Even at the correct temperature, prolonged transit times trigger the breakdown of blood cells caught in the fluid. Outside a living organism, these cells die rapidly; their internal protein structures burst outward, clotting the test gel and rendering the result completely unreadable. By the way, don't sweat the 6% loss: your brain replenishes CSF continuously and rapidly, manufacturing about half a liter of this fluid every single day.

Now, let's look at the test itself. To measure how many B-cell clones are printing antibodies and tracking their manufacturing speed, we have to sort them out somehow. Laboratories use a method called isoelectric focusing—a specialized technique that separates immunoglobulins based on their isoelectric point, which is the exact pH level where the antibody's electrical charge drops to zero. Essentially, the CSF is poured onto a gel matrix with a built-in pH gradient. Antibodies from different clonal families lose their charge at different acidity levels, settling across the gel in visible "oligoclonal bands" that map back to specific B-cell lineages. Every single band is the footprint of a distinct clan of autoimmune hunters printing antibodies modeled on their progenitor's receptor.

I think it's time to pause and roll out the analogy I promised at the start. Picture the CSF as an active combat zone, and the activated autoimmune B-lymphocytes as soldiers armed with machine guns. Each soldier's gun is loaded with a unique color of tracer ammunition. These B-cells can multiply by splitting, but the guns and tracers carried by their copies remain identical to the original, which means the spent cartridges—the antibodies—left on the battlefield carry the exact same color signature. If you collect and sort these cartridges across different sectors of the field, you can calculate exactly how aggressively a specific soldier and his clone platoon were firing their weapons.

Before drawing any macro conclusions, it's worth noting that in about 10% of cases, the biological sample degrades and fails to throw up clean, visible bands. This is almost always a logistics issue: the sample hits the lab spoiled because lymphocytes ruptured in transit, bleeding their internal protein noise into the fluid and clogging the gel, making the matrix unreadable. Pay close attention: this happens in no more than 10% of cases, yet this exact variable is why so many neurologists repeat the mantra that "the spinal tap is non-informative." The reality is uglier: the majority of them have never bothered to look into how the lab analysis is actually conducted; they simply echo a position widely accepted within their professional echo chamber. For context: routine tests for streptococcus, staphylococcus, herpes, chlamydia, and tuberculosis show an identical false-negative rate. Have you ever heard a doctor claim that a tuberculosis test is "non-informative"?

At this point, we need to clarify a highly counterintuitive fact: the antibodies discovered in the CSF are almost never targeted at myelin proteins. Oligoclonal bands do not show how many layers of nerve insulation are under active assault—they merely flag the presence of B-cells inside the brain tissue actively driving an autoimmune crossfire. The primary destructive role of B-cells in the pathogenesis of multiple sclerosis is venting toxic signaling molecules and managing antigen presentation. As for the antibodies themselves, the majority are not specific to myelin at all, yet their presence proves that a localized, autonomous autoimmune firefight is tearing through the brain. Statistically, if you find OCBs in a randomly drawn CSF sample, there is roughly a 65% probability that multiple sclerosis is driving the ignition.

By the way, antibodies targeted specifically at myelin do exist inside the brain; they just rarely manage to drift down into the CSF. The plasma cells manufactured to hunt myelin are surrounded by their target antigen literally on all sides. Their tracers lock onto their targets before they can ever wash out into the spinal fluid. Science calls this the "sponge effect": the moment an antibody rolls off the assembly line, it hits its target right outside the factory doors. Myelin fills the brain in massive volumes, functioning like a vacuum sponge that instantly absorbs every antibody engineered to dismantle it. Here is the ultimate irony: the single most critical laboratory analysis for exposing multiple sclerosis contains every imaginable antibody profile—except the ones actively tearing down your myelin sheaths.

Here is another detail proving how non-linear the immune grid can be: in about 5% of genuine MS cases, B-cells fail to establish dominant clonal lines, resulting in an absence of visible OCBs in the CSF analysis. In these tracks, the brain inflammation is termed "polyclonal," meaning hundreds of distinct B-cell families are participating, with each family manufacturing only a moderate volume of antibodies. On the laboratory gel, they spread out perfectly evenly without grouping into distinct, visible bands. Consequently, even an flawlessly executed spinal tap can yield a Type 1 synthesis profile (no bands) while multiple sclerosis continues to advance inside the brain along a polyclonal script. It is highly likely that this specific exception is what manufactured the widespread myth that lumbar punctures are completely useless.